Cargando…
The positive correlation of TIPRL with LC3 and CD133 contributes to cancer aggressiveness: potential biomarkers for early liver cancer
Studies have reported dysregulation of TIPRL, LC3 and CD133 in liver cancer tissues. However, their respective relationships to liver cancer and roles as biomarkers for prognosis and diagnosis of liver cancer have never been studied. Here we report that the level of TIPRL is significantly correlated...
Autores principales: | Jun, Soo Young, Jeon, Su-Jin, Yoon, Ji-Yong, Lee, Jeong-Ju, Yoon, Hyang Ran, Choi, Min-Hyuk, Halder, Debasish, Lee, Kwangho, Kim, Nam-Soon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856114/ https://www.ncbi.nlm.nih.gov/pubmed/31727942 http://dx.doi.org/10.1038/s41598-019-53191-5 |
Ejemplares similares
-
The Human TOR Signaling Regulator Is the Key Indicator of Liver Cancer Patients’ Overall Survival: TIPRL/LC3/CD133/CD44 as Potential Biomarkers for Early Liver Cancers
por: Jun, Soo Young, et al.
Publicado: (2021) -
TIPRL potentiates survival of lung cancer by inducing autophagy through the eIF2α-ATF4 pathway
por: Jeon, Su-Jin, et al.
Publicado: (2019) -
Novel indazole-based small compounds enhance TRAIL-induced apoptosis by inhibiting the MKK7-TIPRL interaction in hepatocellular carcinoma
por: Yoon, Ji-Yong, et al.
Publicado: (2017) -
Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018) -
TIPRL, a Novel Tumor Suppressor, Suppresses Cell Migration, and Invasion Through Regulating AMPK/mTOR Signaling Pathway in Gastric Cancer
por: Luan, Meng, et al.
Publicado: (2020)